• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Microneedle Drug Delivery Systems to 2018

  • ID: 2729428
  • January 2014
  • Greystone Associates

Microneedle technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer new classes of compounds with significant therapeutic potential. The widespread availability of rapid throughput screening is accelerating the discovery of new drugs, a significant number of which are large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration.


- Provides assessments of microneedles drug delivery devices, patches, syringes and systems

- Analyzes and evaluates microneedle technology and assesses the medical market potential for existing and probable future products

- Provides detailed descriptions of microneedle system business opportunities, market demographics, and business strategies

- Provides market data and forecasts to 2018

- Profiles microneedle drug delivery product and technology participants, their activities, business strategies, and corporate alliances and affiliations

Note: Product cover images may vary from those shown

Executive Summary

Microneedle Medical Market Overview

Drug Delivery & Self-Administration
Chronic Conditions & Dosing Frequency
Patient Safety and Compliance
Microneedle Market Drivers
The Trend to Minimally Invasive Medicine
Shifting Patient Demographics
Managed Care Initiatives
Government Technology Transfer Programs

Microneedle Design & Technology

Microneedle Form Factors
Solid Microneedles
Hollow Microneedles
Coated Microneedles
Dissolvable Microneedles
Microneedle Arrays & Array Geometries
Microneedle Manufacturing
Material Selection Issues
Fabrication Techniques
Emerging Fabrication Methods

Medical Microneedles – Assessments & Commercialization Prospects

Solid Microneedle Arrays

Hollow Microneedle Arrays

Silicon Microneedles

Phase Transition Microneedle Patch

Dissolving Microneedle Chip

Syringe Mounted Microneedles

Programmable Microneedle Patch

Near-Terms Markets - Sector Assessments and Forecasts

Dermatology/Cosmetic Surgery
Genetic/DNA/Nucleotide Therapeutics
Reproductive Medicine

Company Profiles

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Bayer AG LEO Laboratories Ltd. Grünenthal GmbH Medtronic, Inc. Teva Pharmaceutical Industries Ltd. Pall Corporation